What You Should Know:
Hellman & Friendman LLC and Bain Capital acquire health IT company athenahealth for $17 billion dollars.
Private Equity firms Bain Capital and Hellman & Friedman LLC has announced it has acquired athenahealth, a cloud-based enterprise software solution for medical groups and health systems for $17B. In September, it was reported PE firm Veritas Capital and hedge fund Elliot Investment were exploring options to sell athenahealth for $20B or file for an
Read More
Most Popular
Color Raises $100M at $4.6B Valuation to Expand Accessible, Equitable Public Health Infrastructure
What You Should Know:
- Color, a San Francisco, CA-based health technology company committed to advancing public health, announced a $100 million Series E financing round at a valuation of $4.6 billion led by Kindred Ventures and by certain funds and accounts advised by T. Rowe Price Associates, Inc. with participation by existing investors General Catalyst, Viking Global Investors, and Emerson Collective.
- Color makes population-scale healthcare programs accessible, convenient, and
Read More
GE to Form Tax-Free Spin-Off of GE Healthcare Focused on Precision Health
What You Should Know:
Today, GE announced plans to form a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023.
The announcement is part of GE plans to form three independent industry-leading, global, investment-grade public companies focused on the growth sectors of aviation, healthcare and energy.
GE is on track to reduce debt by more than $75 billion by the end of 2021 and is now on track to bring its net-debt-to-EBITDA*
Read More
Senior Companion Platform Papa Raises $150M at $1.4B Valuation
What You Should Know:
- Senior companion and support platform Papa, today announced a $150M in Series D funding to extend the reach and scale of Papa’s innovative solution. With a valuation of $1.4B, this funding round, led by SoftBank Vision Fund 2 and with participation from TCG, Tiger Global Management, Canaan, Initialized Capital and Seven Seven Six, brings Papa’s total funding to $240 million.
- Since its 2017
Read More
Decentralized Clinical Trials: Keys to Optimizing Diversity and Inclusion
The U.S. pharma industry and research intuitions have long struggled with increasing clinical trial diversity in an effective, sustainable, and scalable fashion. Clinical research, in general, acknowledges the universal struggle of recruiting enough participants from various demographic groups. For example, racial and ethnic minorities have been historically underrepresented in clinical trials—a problem that still persists today.
According to Deloitte, African Americans comprise 13% of the
Read More
Notable Secures $100M to Expand Intelligent Automation in Healthcare
What You Should Know:
- Notable, a San Mateo, CA-based leader in healthcare intelligent automation, today announced it has raised $100M in Series B funding led by ICONIQ Growth, including participation by Greylock, F-Prime Capital, and Oak HC/FT to accelerate growth and innovation within the healthcare industry.
- The company plans to use the new round of funding to pioneer a novel intelligent automation approach for healthcare with the mission of reducing administrative burden
Read More
Kareo and PatientPop Merge to Form Tebra to Create All-in-One Practice Platform
What You Should Know:
- Kareo, a provider of cloud-based clinical and financial software, and PatientPop, a provider of practice growth technology, today announced the closing of their merger and the unveiling of the combined company’s new name, Tebra.
- The name Tebra is derived from the word “vertebrae” and symbolizes the role the new company serves as the backbone of practice success, delivering digital technology to connect providers and their patients. The combined company currently
Read More
Medable Secures $304M at $2.1B Valuation for Decentralized Clinical Trials Platform
What You Should Know:
- Decentralized Clinical Trials (DCT) leader Medable, today announced a $304M Series D funding round today – the company’s largest and fourth funding round in 18 months, bringing total capital raised to $521M – and valuation to $2B+. The funding round was co-led by new investors Blackstone Growth and Tiger Global and existing investor GSR Ventures. The round also includes follow-on investment from existing investors Sapphire
Read More
Veta Health Apoints CEO, Walgreens Leadership Appointments, Walmart’s New VP, Other Executive Appointments
Veta Health, a global provider of digital solutions for remote patient care and chronic condition monitoring appoints James Sutcliffe as Chief Executive Officer. Sutcliffe will guide the strategic direction of the company with an emphasis on key commercial dynamics. Founders Tanvi Vattikuti Abbhi and Dr. Nora Zetsche will assume the roles of chief strategy officer and chief medical officer, respectively.
Proactive MD appoints Dr. Saria Saccocio, M.D., as its new president, to continue
Read More
23andMe Acquires Lemonaid Health for $400M – Health M&A
What You Should Know:
- Consumer genetics and research company 23andMe, today announced a definitive merger agreement with Lemonaid Health, Inc., an on-demand platform for accessing medical care and pharmacy services online.
- As part of the merger agreement, 23andMe acquired Lemonaid Health for $400M, of which 25% will be paid in cash and 75% in shares of 23andMe Class A Common Stock. The acquisition is expected to close by the end of 2021.
- The acquisition adds Lemonaid Health’s
Read More
